Current portfolio

Meine Radiologie / Blikk

Meine Radiologie (MRH) and Blikk together form a leading radiology and radiotherapy
platform in Germany offering the full range of radiological, nuclear medical and
radiotherapy treatments through outpatient sites and hospital co-operations.

  • Sektor
    Healthcare
  • Land
    Germany
  • Ansvarig Advisor
    Johann-Christoph Balzer
  • Fond
    EQT Infrastructure V
  • Entry
    2021
Logo

Meine Radiologie (MRH) and Blikk together form a leading radiology and radiotherapy platform in Germany offering the full range of radiological, nuclear medical and radiotherapy treatments through outpatient sites and hospital co-operations.

MRH and Blikk were both founded in 2017 and have since then grown to become two highly reputable radiology and radiotherapy players in Germany rooted in the long-lasting medical experience from their respective management teams and local practices.

The two companies together employ more than 1,300 people across 65 locations, where they provide their services through outpatient clinics and long-term co-operations with hospitals.

The combination of the two groups creates the largest operator in Germany with a broad national footprint and a shared vision to become a reference patient centric radiology and radiotherapy provider at the forefront of medical excellence and technological capabilities.

Market Trends and Drivers

Radiology and radiotherapy are highly essential and fast-growing sub-sectors in social infrastructure and healthcare, driven by positive demographic and technological trends such as ageing population, growing patient demand for preventive measures and technological developments in imaging diagnostics and data analytics.

The German market is underpinned by a stable system that nurtures innovation and high-quality medical services and remains highly fragmented providing ample opportunities for organic and inorganic growth.

Investment Potential

EQT Infrastructure V is committed to support the long-term development of the combined group and to provide the necessary resources to accelerate investments in technology, innovation and human capital in order to continue enhancing medical excellence, expanding capabilities in adjacent specialties, driving an ambitious digitalization agenda and further consolidate the market. A European expansion and new technologies are potential additional upsides for the combined group.

Board of directors

  • Chairperson
    Walter Märzendorfer
  • Board member
    Giuseppe Giannasio
  • Board member
    Liselott Kilaas
  • Board member
    Ralf Michels
  • Board member
    Tobias Küng
  • Board member
    Lucas Herbert
  • Board member
    Christoph Balzer

Prenumerera

Prenumerera på EQT:s press releaser, regulatoriska press releaser och updates.

Typ av nyheter
Preferred language
EQT logo
En syftesdriven global investeringsorganisation
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180